Daniel J Murphy

researcher

Daniel J Murphy is …
instance of (P31):
humanQ5

External links are
P496ORCID iD0000-0002-5538-5468

P1416affiliationUniversity of VirginiaQ213439
P69educated atUniversity of VirginiaQ213439
University of ScrantonQ2495907
P108employerUniversity of WürzburgQ161976
University of GlasgowQ192775
P734family nameMurphyQ1953798
MurphyQ1953798
MurphyQ1953798
P735given nameDanielQ14516546
DanielQ14516546
P106occupationresearcherQ1650915
P21sex or gendermaleQ6581097

Reverse relations

author (P50)
Q57814748A Neuronal Relay Mediates a Nutrient Responsive Gut/Fat Body Axis Regulating Energy Homeostasis in Adult Drosophila
Q38769261An important role for Myb-MuvB and its target gene KIF23 in a mouse model of lung adenocarcinoma.
Q52431522Author Correction: CRISPR/Cas9-derived models of ovarian high grade serous carcinoma targeting Brca1, Pten and Nf1, and correlation with platinum sensitivity.
Q35236066BIM is the primary mediator of MYC-induced apoptosis in multiple solid tissues
Q42240438BIM's up first
Q47141255CRISPR/Cas9-derived models of ovarian high grade serous carcinoma targeting Brca1, Pten and Nf1, and correlation with platinum sensitivity
Q47652919Calcium signalling links MYC to NUAK1.
Q52689064Colorectal Tumors Require NUAK1 for Protection from Oxidative Stress.
Q39372073Deregulated MYC expression induces dependence upon AMPK-related kinase 5.
Q30850824Development of an inducible mouse model of iRFP713 to track recombinase activity and tumour development in vivo
Q47169512Developmental Regulation of Mitochondrial Apoptosis by c-Myc Governs Age- and Tissue-Specific Sensitivity to Cancer Therapeutics
Q34897529Distinct thresholds govern Myc's biological output in vivo
Q28083964Evidence of cancer-promoting roles for AMPK and related kinases
Q91007696Glutamine Anabolism Plays a Critical Role in Pancreatic Cancer by Coupling Carbon and Nitrogen Metabolism
Q30303653Human SWI-SNF component BRG1 represses transcription of the c-fos gene
Q98616855IKKβ Kinase Promotes Stemness, Migration, and Invasion in KRAS-Driven Lung Adenocarcinoma Cells
Q36421368Id2 is dispensable for Myc-induced epidermal neoplasia.
Q64981693Identification of a Clinically Relevant Signature for Early Progression in KRAS-Driven Lung Adenocarcinoma.
Q27329469In vitro evidence for senescent multinucleated melanocytes as a source for tumor-initiating cells.
Q40018172Inhibition of cyclin D1 gene transcription by Brg-1.
Q24746259Interleukin-6- and cyclic AMP-mediated signaling potentiates neuroendocrine differentiation of LNCaP prostate tumor cells.
Q54999834Is oxidative stress MYC’s Achilles heel?
Q35156829Limited mitochondrial permeabilization causes DNA damage and genomic instability in the absence of cell death
Q47111931MYC regulates ductal-neuroendocrine lineage plasticity in pancreatic ductal adenocarcinoma associated with poor outcome and chemoresistance.
Q50120813Mesothelioma: Identical Routes to Malignancy from Asbestos and Carbon Nanotubes
Q34811008Modelling Myc inhibition as a cancer therapy
Q36547736Oncogene-dependent tumor suppression: using the dark side of the force for cancer therapy.
Q36348789Oncogenic Myc Induces Expression of Glutamine Synthetase through Promoter Demethylation
Q40169633Predicting lung cancer recurrence from circulating tumour DNA. Commentary on 'Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution'.
Q50056410Progress and challenges in Mesothelioma: From bench to bedside
Q90569268Repression of the Type I Interferon pathway underlies MYC & KRAS-dependent evasion of NK & B cells in Pancreatic Ductal Adenocarcinoma
Q112302375THEM6-mediated reprogramming of lipid metabolism supports treatment resistance in prostate cancer
Q54999844The 2014 Beatson International Cancer Conference: Powering the Cancer Machine
Q56929860The ERBB network facilitates KRAS-driven lung tumorigenesis
Q52586930The Spy1/RINGO family represents a novel mechanism regulating mammary growth and tumorigenesis.
Q112654377The pathogenesis of mesothelioma is driven by a dysregulated translatome

Search more.